As fears of global pandemics have been used by the World Health Organization and governments around the world to push for increasingly aggressive vaccination programs, questions about safety continue to be raised. These concerns have largely been downplayed by governments, regulatory agencies, and the pharmaceutical industry. Contrary to a widespread belief that vaccine safety is completely and unequivocally established, the work of a number of scientists suggests that the opposite might be true.
Similar concerns about the safety of GMO food products, additives, endocrine disruptors, pathogens and toxicity in the water supply and other environmental factors should be addressed with rigorous controlled research.
It is expected that the results of the research funded by CMSRI, founded by Claire Dwoskin, will have a profound impact on the development of health policies concerning vaccines and will serve to provide science-based information for the general public.
The current model of government and industry-sponsored research utilizes research methods which sanction the use of active placebos and active controls, which may be masking background levels of adverse reactions. Subjects are followed for relatively short time frames in relation to the biological activity and reactivity of the components, preparations and combinations under review. Passive surveillance is inadequate to assess both short and long term health consequences at the population level due to under reporting and lack of scientific certainty of the relationship between the vaccines and health effects. The government sponsored research is primarily epidemiological. Bench science is needed to examine the biological, molecular, and physiological impacts on blood tissue, genes, neurological and immune systems.
Vaccines are administered to infants and young children during a period of rapid development of the neurological and immune systems and to older adults regardless of prior exposures or existing health conditions without an understanding of the genetic and biological impacts on those systems. Previously, research has not been funded by health authorities to conduct comprehensive studies of the biological and genetic changes which take place after exposure to vaccine ingredients, preparations, combinations and schedules. In specific, the entire vaccine schedule has never been examined in its entirety for safety, nor have the various combinations been studied that might be administered on a routine basis.
CMSRI’s current research focus is on vaccine safety due to high levels of and further expected increases in vaccination. CMSRI has established an international collaboration of independent scientists, physicians, experts in vaccine regulation, social science, environmental and health policy, and consumer child health advocates to establish vaccine safety research priorities and agenda to address the need for high quality methodologically sound safety research into the gaps in the knowledge about:
- biological mechanisms and genetic and biological high risk factors for vaccine induced brain and immune dysfunction, including lack of adequate safety data, particularly for delayed or chronic health outcomes;
- vaccine additives such as aluminum adjuvants (immune stimulating agents), mercury preservatives, and other toxins like formaldehyde, sodium borate and polysorbate 80, foreign proteins from the culture medium such as chicken embryos, monkey kidneys and cells from aborted fetal tissue and viral DNA;
- multiple vaccine exposures;
- bias in reporting of vaccine risks and benefits; and
- novel vaccine-associated autoimmune diseases. The CMSRI collaborative approach will maximize the potential for discovery beyond what could be achieved in an individual laboratory. CMSRI’s research projects will expand to additional areas as the foundation resources grow.
CMSRI will conduct research on a range of issues from the toxic potential of various vaccine ingredients to the expression of human diseases. The overall goal of the institute is to provide a critical body of research of the existing data on vaccine safety, expanded research to include acknowledged gaps in the science and a continued evaluation of what further research is needed in the future.